Nuveen Select Tax-Free Income Portfolio

NYSE:NXP

14.24 (USD) • At close May 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22010 Q42010 Q2
Revenue 15.98215.35614.82314.53310.93910.1914.8155.4215.0475.5775.4155.0815.0224.9245.034.9745.0455.095.2935.1685.5345.8335.7295.9166.27900
Cost of Revenue 01.466-1.4660000000.3250.3130000000000000000
Gross Profit 15.98213.8916.28914.53310.93910.1914.8155.4215.0475.2525.1015.0815.0224.9245.034.9745.0455.095.2935.1685.5345.8335.7295.9166.27900
Gross Profit Ratio 10.9051.0991111110.9420.9421111111111111100
Reseach & Development Expenses 000000000000000000000000000
General & Administrative Expenses 0.8340.7960.7750.7650.8680.6590.3490.3520.3450.1790.1690.3280.3320.3410.3490.3520.3640.3520.3540.3510.4460.3420.3420.340.35700
Selling & Marketing Expenses 000000000000000000000000000
SG&A 0.8340.7960.7750.7650.8680.6590.3490.3520.3450.1790.1690.3280.3320.3410.3490.3520.3640.3520.3540.3510.4460.3420.3420.340.35700
Other Expenses 000000000-09.0890000000000000000
Operating Expenses 0.8340.7960.77533.35859.12558.9080.2282.6495.3952.936-9.0897.392.0595.2326.514.4485.5758.3894.1553.79910.1336.54817.330.0467.27300
Operating Income 15.14814.5614.04713.76810.079.5324.4665.0694.701-0.76114.194.7524.694.5834.6824.6224.6814.7384.9384.8175.0885.495.3875.5775.92300
Operating Income Ratio 0.9480.9480.9480.9470.9210.9350.9270.9350.932-0.1362.6210.9350.9340.9310.9310.9290.9280.9310.9330.9320.9190.9410.940.9430.94300
Total Other Income Expenses Net 4.89640.259-37.46834.123-58.261-58.2490.1213.0015.7410020.188-1.727-4.8916.849-22.68216.1968.463-3.8892.6139.8176.656-16.9880.2947.6300
Income Before Tax 20.04554.819-23.4247.892-48.191-48.7174.5868.0710.442-014.1912.472.963-0.30811.53-9.0310.43813.2011.057.43114.90512.147-11.6015.87113.55300
Income Before Tax Ratio 1.2543.57-1.583.295-4.406-4.780.9531.4892.069-02.6212.4540.59-0.0632.292-1.8152.0692.5940.1981.4382.6932.082-2.0250.9922.15800
Income Tax Expense 00034.123-58.266-58.2490.1213.0015.741-04.6967.718-1.727-4.8916.849-13.6525.5768.184-3.9771.0779.0556.422-16.9880.2947.6300
Net Income 20.04554.819-23.4247.892-48.191-48.7174.5868.0710.44216.57814.1912.472.963-0.30811.53-9.0310.43813.2011.057.43114.90512.147-11.6015.87113.55300
Net Income Ratio 1.2543.57-1.583.295-4.406-4.780.9531.4892.0692.9722.6212.4540.59-0.0632.292-1.8152.0692.5940.1981.4382.6932.082-2.0250.9922.15800
EPS 0.411.14-0.491.02-1.02-1.040.280.480.6210.860.760.179-0.0190.7-0.540.620.80.0630.440.90.74-0.70.360.8200
EPS Diluted 0.411.14-0.491.02-1.02-1.040.280.480.6210.860.760.179-0.0190.7-0.540.620.80.0630.440.90.74-0.70.360.8200
EBITDA 000000000-0.76114.1900-5.1990-18.0600000000.2947.6300
EBITDA Ratio 000000000-0.1362.62100-1.0560-3.63100000000.051.21500